TXG Operating Cash Flow (Statement)
10X Genomics Inc Class A · Operating Cash Flow (Statement)
TXG Operating Cash Flow (Statement)
Latest reported$127.09Mperiod ending
TXG Cash from Operations (-$10.70M → $127.09M)
Annual operating cash flow (statement)
High-resolution chart · PNG
TXG operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 136,050,000 | |
| 6,664,000 | |
| -15,197,000 | |
| -33,606,000 | |
| -21,373,000 | |
| -217,898,000 | |
| 34,627,000 | |
| -76,409,000 | |
| -10,699,000 |